Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hanley

Showing results (611-620 of 740) with videos related to

Pageof 74
Sort By:
Diabetes Research and Clinical Practice|February 12, 2020
Closing the indigenous health gap in Canada: Results from the TransFORmation of IndiGEnous PrimAry HEAlthcare delivery (FORGE AHEAD) programMariam Naqshbandi Hayward, Romina Pace, Harsh Zaran, et al.
Molecular Therapy. Methods & Clinical Development|November 14, 2019
HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing PlatformShabnum Patel, Ryo Hanajiri, Melanie Grant, et al.
The Journal of Nutrition|September 5, 2020
Maternal Diet and Infant Feeding Practices Are Associated with Variation in the Human Milk Microbiota at 3 Months Postpartum in a Cohort of Women with High Rates of Gestational Glucose IntoleranceLauren LeMay-Nedjelski, Michelle R Asbury, James Butcher, et al.
British Journal of Haematology|May 20, 2016
A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysisNeeraj Gupta, Michael J Hanley, R Donald Harvey, et al.
Science Signaling|July 29, 2010
Autocrine purinergic receptor signaling is essential for macrophage chemotaxisMoritz Kronlage, Jian Song, Lydia Sorokin, et al.
Blood Advances|July 23, 2020
Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapyJeremy D Rubinstein, Xiang Zhu, Carolyn Lutzko, et al.
International Journal of Circumpolar Health|February 4, 2017
Traditional foods and 25(OH)D concentrations in a subarctic First Nations communitySudaba Mansuri, Alaa Badawi, Sheena Kayaniyil, et al.
Cytotherapy|March 14, 2013
Manufacturing mesenchymal stromal cells for phase I clinical trialsPatrick J Hanley, Zhuyong Mei, Maria da Graca Cabreira-Hansen, et al.
Diabetologia|October 12, 2012
The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS)C C Lee, C Lorenzo, S M Haffner, et al.
Molecular Therapy. Methods & Clinical Development|October 2, 2020
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIVAllison B Powell, Yanqin Ren, Maria Korom, et al.
Pageof 74

Showing results (611-620 of 740) with videos related to

Sort By:
Pageof 74
Diabetes Research and Clinical Practice|February 12, 2020
Closing the indigenous health gap in Canada: Results from the TransFORmation of IndiGEnous PrimAry HEAlthcare delivery (FORGE AHEAD) programMariam Naqshbandi Hayward, Romina Pace, Harsh Zaran, et al.
Molecular Therapy. Methods & Clinical Development|November 14, 2019
HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing PlatformShabnum Patel, Ryo Hanajiri, Melanie Grant, et al.
The Journal of Nutrition|September 5, 2020
Maternal Diet and Infant Feeding Practices Are Associated with Variation in the Human Milk Microbiota at 3 Months Postpartum in a Cohort of Women with High Rates of Gestational Glucose IntoleranceLauren LeMay-Nedjelski, Michelle R Asbury, James Butcher, et al.
British Journal of Haematology|May 20, 2016
A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysisNeeraj Gupta, Michael J Hanley, R Donald Harvey, et al.
Science Signaling|July 29, 2010
Autocrine purinergic receptor signaling is essential for macrophage chemotaxisMoritz Kronlage, Jian Song, Lydia Sorokin, et al.
Blood Advances|July 23, 2020
Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapyJeremy D Rubinstein, Xiang Zhu, Carolyn Lutzko, et al.
International Journal of Circumpolar Health|February 4, 2017
Traditional foods and 25(OH)D concentrations in a subarctic First Nations communitySudaba Mansuri, Alaa Badawi, Sheena Kayaniyil, et al.
Cytotherapy|March 14, 2013
Manufacturing mesenchymal stromal cells for phase I clinical trialsPatrick J Hanley, Zhuyong Mei, Maria da Graca Cabreira-Hansen, et al.
Diabetologia|October 12, 2012
The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS)C C Lee, C Lorenzo, S M Haffner, et al.
Molecular Therapy. Methods & Clinical Development|October 2, 2020
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIVAllison B Powell, Yanqin Ren, Maria Korom, et al.
Pageof 74